Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of MenB Vaccine in Toddlers
NCT00847145Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Aug 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal disease, sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00847145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847145.